pathogen antigen microarrays (Arrayit Corporation)
90
Structured Review
Arrayit Corporation
pathogen antigen microarrays

Pathogen Antigen Microarrays, supplied by Arrayit Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/omicsarray%E2%84%A2+antigen+microarray+profiling+services/pathogen+antigen+microarray+kits/pmc06680274-12-8-5
Average 90 stars, based on 1 article reviews

Pathogen Antigen Microarrays, supplied by Arrayit Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/omicsarray%E2%84%A2+antigen+microarray+profiling+services/pathogen+antigen+microarray+kits/pmc06680274-12-8-5
Average 90 stars, based on 1 article reviews
pathogen antigen microarrays - by Bioz Stars,
2026-11
90/100 stars
Images
1) Product Images from "ELISA in the multiplex era: Potentials and pitfalls"
Article Title: ELISA in the multiplex era: Potentials and pitfalls
Journal: Proteomics. Clinical Applications
doi: 10.1002/prca.201400130
Figure Legend Snippet: Commercially available multiplex arrays suitable for a variety of clinical indications
Techniques Used: Multiplex Assay, Luminex, Enzyme-linked Immunosorbent Assay, Flow Cytometry
1 , but with a ‘+’ in this table" title="Commercially available multiplex arrays suitable for IVD, which have demonstrated clinical viability and ... " property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: Commercially available multiplex arrays suitable for IVD, which have demonstrated clinical viability and applicability in pre‐clinical validation studies but not demonstrated complete compliance with regulatory parameters (at time of writing) are designated with a ‘–’ in Table
Techniques Used: Multiplex Assay, Enzyme-linked Immunosorbent Assay
Related Articles
Microarray:Article Title: Protein microarray technology: how far off is routine diagnostics? Article Snippet: The nature of proteinmicroarray platforms is favorable for multiplexing, leading to the development of tools for personalised medicine and highly precise diagnostics.. However, to date, only a limited number of protein microarrays are available in the in vitro diagnostics (IVD) market.. This review article will focus on the following operational challenges that are crucial for the use of microarrays in clinical settings: (1) probe printing and quality control; (2) procurement of bio-reagents and antibody cross-reactivity; (3) mass transport limitations and assay automation; (4) calibration and quantification. Article Title: Protein microarray technology: how far off is routine diagnostics? Article Snippet: The nature of proteinmicroarray platforms is favorable for multiplexing, leading to the development of tools for personalised medicine and highly precise diagnostics.. However, to date, only a limited number of protein microarrays are available in the in vitro diagnostics (IVD) market.. This review article will focus on the following operational challenges that are crucial for the use of microarrays in clinical settings: (1) probe printing and quality control; (2) procurement of bio-reagents and antibody cross-reactivity; (3) mass transport limitations and assay automation; (4) calibration and quantification. other:Article Title: ELISA in the multiplex era: Potentials and pitfalls Article Snippet: |